350 related articles for article (PubMed ID: 31838822)
1. [Prediction model for survival in patients with biliary tract cancer: a development and validation study].
Han L; Cui P; Tang MS; Zhang M; Cui HJ; Zeng ZQ; Chen SY; Liu SS; Song B; Gu DQ; Wang X; Zhang B
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1461-1469. PubMed ID: 31838822
[No Abstract] [Full Text] [Related]
2. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
3. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.
Castro FA; Koshiol J; Hsing AW; Devesa SS
Int J Cancer; 2013 Oct; 133(7):1664-71. PubMed ID: 23504585
[TBL] [Abstract][Full Text] [Related]
4. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
[TBL] [Abstract][Full Text] [Related]
5. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
8. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
Goodman MT; Yamamoto J
Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
[TBL] [Abstract][Full Text] [Related]
9. Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study.
Chen Z; Lin RM; Bai YK; Zhang Y
Biomed Res Int; 2019; 2019():8293261. PubMed ID: 31032364
[TBL] [Abstract][Full Text] [Related]
10. Nomograms for predicting survival in early-onset esophageal cancer.
Shi M; Tang JW; Cao ZR
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):437-446. PubMed ID: 33121317
[No Abstract] [Full Text] [Related]
11. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.
Huang JF; Chen D; Sang CM; Zheng XQ; Lin JL; Lin Y; Ni WF; Wang XY; Li YM; Wu AM
World Neurosurg; 2019 Aug; 128():e603-e614. PubMed ID: 31054340
[TBL] [Abstract][Full Text] [Related]
13. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.
Wang SJ; Fuller CD; Kim JS; Sittig DF; Thomas CR; Ravdin PM
J Clin Oncol; 2008 May; 26(13):2112-7. PubMed ID: 18378567
[TBL] [Abstract][Full Text] [Related]
14. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
[TBL] [Abstract][Full Text] [Related]
15. A predictive model for survival of gallbladder adenocarcinoma.
Yifan T; Zheyong L; Miaoqin C; Liang S; Xiujun C
Surg Oncol; 2018 Sep; 27(3):365-372. PubMed ID: 30217289
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.
Song W; Lv CG; Miao DL; Zhu ZG; Wu Q; Wang YG; Chen L
Eur J Surg Oncol; 2018 Oct; 44(10):1657-1665. PubMed ID: 30082175
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Nomograms to Predict Survival of Patients with Resectable Gallbladder Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Based Analysis.
Lin Y; Chen H; Pan F
Med Sci Monit; 2021 Mar; 27():e929106. PubMed ID: 33784268
[TBL] [Abstract][Full Text] [Related]
18. Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study.
Zhou H; Zou X; Li H; Chen L; Cheng X
Jpn J Clin Oncol; 2020 Dec; 50(12):1386-1394. PubMed ID: 32776099
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.
Kim BW; Oh CM; Choi HY; Park JW; Cho H; Ki M
Gut Liver; 2019 Jan; 13(1):104-113. PubMed ID: 29938462
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in gallbladder and biliary tract cancer.
Gómez-Roel X; Arrieta O; León-Rodríguez E
Med Oncol; 2007; 24(1):77-83. PubMed ID: 17673815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
